- Home
- OESX vs CLGN Comparison
OESX vs CLGN Comparison
Compare OESX & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OESX
- CLGN
- Stock Information
- Founded
- OESX 1996
- CLGN 2004
- Country
- OESX United States
- CLGN Israel
- Employees
- OESX N/A
- CLGN N/A
- Industry
- OESX Building Products
- CLGN Industrial Specialties
- Sector
- OESX Consumer Discretionary
- CLGN Health Care
- Exchange
- OESX Nasdaq
- CLGN Nasdaq
- Market Cap
- OESX 19.3M
- CLGN 19.1M
- IPO Year
- OESX 2007
- CLGN N/A
- Fundamental
- Price
- OESX $0.60
- CLGN $1.37
- Analyst Decision
- OESX Strong Buy
- CLGN Strong Buy
- Analyst Count
- OESX 2
- CLGN 2
- Target Price
- OESX $1.75
- CLGN $11.50
- AVG Volume (30 Days)
- OESX 135.4K
- CLGN 127.7K
- Earning Date
- OESX 06-26-2025
- CLGN 08-19-2025
- Dividend Yield
- OESX N/A
- CLGN N/A
- EPS Growth
- OESX N/A
- CLGN N/A
- EPS
- OESX N/A
- CLGN N/A
- Revenue
- OESX $79,720,000.00
- CLGN $2,472,000.00
- Revenue This Year
- OESX $19.97
- CLGN $2,177.67
- Revenue Next Year
- OESX $16.45
- CLGN $56.52
- P/E Ratio
- OESX N/A
- CLGN N/A
- Revenue Growth
- OESX N/A
- CLGN N/A
- 52 Week Low
- OESX $0.56
- CLGN $1.31
- 52 Week High
- OESX $1.12
- CLGN $5.48
- Technical
- Relative Strength Index (RSI)
- OESX 45.72
- CLGN 39.49
- Support Level
- OESX $0.59
- CLGN $1.35
- Resistance Level
- OESX $0.61
- CLGN $1.54
- Average True Range (ATR)
- OESX 0.04
- CLGN 0.14
- MACD
- OESX 0.01
- CLGN -0.02
- Stochastic Oscillator
- OESX 31.54
- CLGN 2.88
About OESX Orion Energy Systems Inc.
Orion Energy Systems Inc is a developer, manufacturer, and seller of lighting and energy management systems. The company segments include Orion Lighting Segment, Orion Maintenance Segment and Orion Electric Vehicle Charging Segment. It derives maximum revenue from Lighting Segment.
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.